- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Ondine Biomedical grants stock options, RSUs and warrants | 1 | Investing.com | ||
| Mo | Ondine Biomedical - Grant of Options and RSUs, and Issue of Warrants | - | RNS | ||
| Do | Ondine Biomedical: Strategiewechsel führt zu Umsatzwachstum und hohem Verlust | 3 | Investing.com Deutsch | ||
| ONDINE BIOMEDICAL Aktie jetzt für 0€ handeln | |||||
| Do | Increased investment sees Ondine Biomedical post widened annual loss | 1 | Alliance News | ||
| Do | Ondine Biomedical setzt jährliche Hauptversammlung für 30. Juni an | 1 | Investing.com Deutsch | ||
| Do | Ondine Biomedical schedules annual meeting for June 30 | 1 | Investing.com | ||
| Do | Ondine Biomedical - Notice of AGM | - | RNS | ||
| Do | Ondine Biomedical - 2025 Full Year Results and Annual Report | - | RNS | ||
| 28.05. | Ondine Biomedical - Notice of Results and Investor Presentation | - | RNS | ||
| 26.05. | Ondine Biomedical - Steriwave ICU Study Outcomes Presented at CSRT2026 | - | RNS | ||
| 06.05. | hInsight-NX reduces stake in Ondine Biomedical to 7.53% | 2 | Investing.com | ||
| 06.05. | Ondine Biomedical - Notification of major holdings - hInsight-NX, LLC | - | RNS | ||
| 06.05. | Ondine Biomedical - Notification of major holdings - Carolyn Cross | - | RNS | ||
| 05.05. | Ondine Biomedical - Notification of major holdings - Pentwater | - | RNS | ||
| 30.04. | Ondine presents nasal infection prevention data at UK conference | 2 | Investing.com | ||
| 30.04. | Ondine Biomedical - Ondine Presented Steriwave Data at IPC 2026 | - | RNS | ||
| 29.04. | Ondine Biomedical - Result of Fundraise & TVR | - | RNS | ||
| 28.04. | Ondine Biomedical plans £5m fundraise at 12p per share | 1 | Investing.com | ||
| 28.04. | Ondine Biomedical will 5 Millionen Pfund über Kapitalerhöhung einwerben | 1 | Investing.com Deutsch | ||
| 28.04. | Ondine Biomedical - Proposed c.£5 million (C$9.23 million) Fundraise | - | RNS |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TANGO THERAPEUTICS | 30,940 | +0,03 % | Tango Therapeutics stock soars on promising pancreatic cancer data | ||
| NURIX THERAPEUTICS | 15,640 | 0,00 % | Roche geht 2,3-Milliarden-Dollar-Deal mit Nurix für Blutkrebsmittel ein | DJ Roche geht 2,3-Milliarden-Dollar-Deal mit Nurix für Blutkrebsmittel ein
Von Nina Kienle
DOW JONES--Roche hat mit dem US-Biotechunternehmen Nurix Therapeutics eine exklusive Lizenz- und Kooperationsvereinbarung... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 14,110 | 0,00 % | All You Need to Know About Summit Therapeutics (SMMT) Rating Upgrade to Buy | ||
| COGENT BIOSCIENCES | 31,160 | 0,00 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) ... | Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2 months (HR=0.50... ► Artikel lesen | |
| QIAGEN | 31,745 | 0,00 % | DEUTSCHE BANK RESEARCH stuft QIAGEN NV auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Qiagen mit einem Kursziel von 43 US-Dollar auf "Buy" belassen. Das Feedback aus Gesprächen mit etlichen US-Laborexperten deute darauf hin, dass... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 82,94 | -0,08 % | RBC Capital raises Apogee Therapeutics stock price target to $97 | ||
| PRAXIS PRECISION MEDICINES | 253,12 | -0,05 % | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| ERASCA | 12,870 | 0,00 % | Erasca, Inc.: Erasca Reports First Quarter 2026 Business Updates and Financial Results | Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targeted... ► Artikel lesen | |
| BEAM THERAPEUTICS | 29,780 | 0,00 % | Beam Therapeutics Inc. - 8-K, Current Report | ||
| AMYLYX PHARMACEUTICALS | 13,010 | 0,00 % | H.C. Wainwright reiterates Amylyx stock rating on PBH trial insights | ||
| KINIKSA PHARMACEUTICALS | 49,040 | 0,00 % | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution | - ARCALYST- (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth -- ARCALYST 2026 expected net product revenue increased to $930 - $945 million -- KPL-387... ► Artikel lesen | |
| MINERALYS THERAPEUTICS | 22,500 | 0,00 % | Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing | - Repurchase of lorundrostat royalty obligation in Tanabe license agreement for $200 million upfront and up to $100 million once certain commercial milestones are met - - $500 million committed... ► Artikel lesen | |
| MONTE ROSA THERAPEUTICS | 17,000 | 0,00 % | Pictet closes $1.53bn Monte Rosa Co-Investments VI fund, exceeding target | ||
| DYNE THERAPEUTICS | 16,820 | +0,06 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1) | - Registrational expansion cohort enrolled 71 participants; topline data planned for Q1 2027 - WALTHAM, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage... ► Artikel lesen | |
| CG ONCOLOGY | 54,36 | -0,07 % | CG Oncology, Inc. - 8-K, Current Report |
ONDINE BIOMEDICAL INC CDIS gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 0,129 Euro und damit +0,78 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONDINE BIOMEDICAL INC CDIS finden Sie auf Wallstreet Online.